Table 5.
Summary of risk factors for atherosclerotic vascular events in five cohorts.
Risk factors | Baltimore2 229 | Pittsburgh3 498 | LUMINA16 546 | Toronto inception15 561 | SLICC 637* |
---|---|---|---|---|---|
Type of cohort | Prevalent | Prevalent | Inception 5 yr | Inception 1 yr | Inception 1 yr |
Older age at Diagnosis | √ | √ | √ | √ | |
Longer duration SLE | √ | √ | √ | ||
Male gender | √ | ||||
Longer duration prednisone use | √ | √ | |||
Hypercholesterolemia | √ | √ | |||
Hypertension | √ | ||||
Postmenopausal status | √ | ||||
Smoking | √ | √ | |||
Neuropsychiatric lupus | √ | ||||
C-reactive protein | √ | ||||
Antiphospholipid antibody | √ |
includes only patients followed for at least 2 years
37 patients in SLICC has also been used in the Toronto inception study but had 3 more year of follow up in the SLICC registry